Article Per Year (5 Year)
p-Index From 2021 - 2026
1.116
P-Index
This Author published in this journals
All Journal Pharmaceutical Journal of Indonesia JURNAL FARMASIMED (JFM) Hubungan Tingkat Pengetahuan Petugas Pengelola Obat dengan Tingkat Ketersediaan Obat Di Puskesmas Kota Malang Al-Mutsla: Jurnal Ilmu-Ilmu Keislaman dan Kemasyarakatan Pappasang Jurnal Farmasi Komunitas
Samirah
Unknown Affiliation
Religion Arts Humanities Biochemistry, Genetics & Molecular Biology Health Professions Immunology & microbiology Languange, Linguistic, Communication & Media Medicine & Pharmacology Public Health Social Sciences Other

Published : 6 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Profile of Antituberculosis Therapy in Tuberculosis Patient with Diabetes Mellitus Paramita, hilda ema; samirah
Pharmaceutical Journal of Indonesia Vol. 10 No. 2 (2025)
Publisher : Brawijaya University

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/

Abstract

Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (M.tb.). People with weak immune conditions such as people with diabetes mellitus (DM) are more susceptible to TB infection. The aim of this research was to review the profile of antituberculosis therapy in pulmonary TB patients with DM. It was a descriptive observational study using retrospective data during period January 1, 2019, to January 31, 2020, which was conducted at Poli TB of Airlangga University Hospital. The samples used were medical records of adult patients over 18 years diagnosed with pulmonary tuberculosis and diabetes mellitus who received antituberculosis therapy and obtained as many as 32 medical records of patients. The results showed that the most widely used antituberculosis was Fixed- dose combination (FDC) asa many as 30 patients (93,8%) and 2 patients in special combination (6,4%). Special combination are given to patients with special conditions such as hypersensitivity to antituberculosis. The dose regimentation of antituberculosis given to the patient with controlled and uncontrolled diabetes during the intensive phase and continuation phase was 2 – 5 tablets of FDC. The patient’s diabetes control was measured by the value of glucose levels during treatment. Antidiabetic treatment given to pulmonary TB patients with DM was insulin in 20 patients (62,5%) and oral antidiabetic drugs (OAD) in 12 patients (37,5%). After obtaining the regimen therapy, most TB patients with controlled diabetes completed the treatment in 6 patients (26,1%) with duration of treatment of 6 months in 4 patients (17.4%) while patients with uncontrolled diabetes completed the treatment in 8 patients (34,8%) with duration of treatment more than 6 months in 9 patients (39,1%). Potential Drug- Related problems (DRP) identified in this research are 18 drug interactions (56,2%) and 14 suspected side effects (43,6%). Based on the results of research treatment and dosage regimens used in pulmonary TB patients with DM in Poli TB of Airlangga University Hospital have been following national TB guidelines
Co-Authors Achmad Abubakar Anggara Satria Putra, Anggara Satria Anik Rahmawati, Anik Broto Anung Laksono Budiatin, Aniek S. Denayu Pebrianti Dudung Abdullah Farah Shafiyya Salsabila Febrinar Hera Rahmaniar Insania Kamilla Putrihana Mochamad Iqbal Jaelani Nafa Nazilatul Fatihah Nur Fahmyta Zairoh Nuro Khoiri Asyhari Nurwahida Paramita, hilda ema Ratri, Dinda MN Risma Septia Indah Fridayanti S Siradjuddin Tarishah Wahyu Ramadhani Toetik Aryani Umi Aida Rohma